Tumor necrosis factor inhibitors were not linked to additional weight gain in patients with psoriatic arthritis when ...

Investigators employed the Accelerating Medicines Partnership to identify noninvasive biomarkers of lupus nephritis pathology and treatment response.

Co-led by Forbion and Sofinnova Partners, along with founding investor Monograph Capital, and WeatherdenInnovative lead program, ELV001, in-licensed by Elevara from Japan’s Teijin Pharma with good ...

Like the surface of the moon, new research published today in Cell finds the existence of craters on the surface of melanoma ...

Like the surface of the moon, new research published today in Cell finds the existence of craters on the surface of melanoma cells that serve as ...

New research published in Cell finds the existence of craters on the surface of melanoma cells that serve as immune hubs, ...

Merck & Co. Inc. (NYSE:MRK) is one of the most promising stocks under $100. On October 6, Merck & Co. announced the ...

Pulmonary fibroblasts coordinate the progression of airway inflammation through multiple pathways. However, the role and underlying mechanisms of its subtype, bronchial fibroblasts, under ...

WESTWEGO, La. — Robin Phillip’s fresh haircut is dyed her favorite color — green. But beneath the dye job is a scar that runs along the side of her head, the result of two craniotomies. For years, ...

A research team has developed an approach to significantly reduce the risk of cancer recurrence and metastasis after surgery, by targeting both bulk cancer cells and the elusive cancer stem cells ...

A Russian man had a hulking tumor the size of his head surgically removed from his neck after more than a decade of using failed home remedies in hopes it would “go away on its own.” The 65-year-old ...

Scientists have engineered Salmonella bacteria to self-destruct inside tumors, releasing signals that spark powerful immune hubs and shrink colon cancer in mice, opening the door to “living medicines” ...